AC
Armistice Capital Portfolio holdings
AUM
$2.64B
This Quarter Return
+0.24%
1 Year Return
+0.99%
3 Year Return
+16.29%
5 Year Return
+18.04%
10 Year Return
+34.8%
AUM
$3.98B
AUM Growth
-$317M
(-7.4%)
Cap. Flow
-$330M
Cap. Flow
% of AUM
-8.28%
Top 10 Holdings %
Top 10 Hldgs %
28.71%
Holding
293
New
68
Increased
46
Reduced
97
Closed
73
Top Buys
| 1 |
Pfizer
PFE
|
$76.9M |
| 2 |
NVRO
NEVRO CORP.
NVRO
|
$59.9M |
| 3 |
Jazz Pharmaceuticals
JAZZ
|
$56.5M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
$51.7M |
| 5 |
Keurig Dr Pepper
KDP
|
$42.1M |
Top Sells
| 1 |
GSK
GSK
|
$105M |
| 2 |
Exact Sciences
EXAS
|
$83M |
| 3 |
Organon & Co
OGN
|
$75.3M |
| 4 |
Biogen
BIIB
|
$55.3M |
| 5 |
Central Garden & Pet Class A
CENTA
|
$53.3M |
Sector Composition
| 1 | Healthcare | 68.27% |
| 2 | Consumer Staples | 10.31% |
| 3 | Technology | 7.85% |
| 4 | Consumer Discretionary | 7.66% |
| 5 | Communication Services | 3.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MKUL
101
DELISTED
Molekule Group, Inc. Common Stock
MKUL
| $7.72M | 0.11% |
+3,299,875
| New | +$7.72M |
|
102
NVIDIA
NVDA
$4.14T
| $7.61M | 0.11% |
180,000
-120,000
| -40% | -$5.08M |
|
|
SPRB
103
DELISTED
Spruce Biosciences, Inc. Common Stock
SPRB
| $7.52M | 0.11% |
3,498,000
-430,000
| -11% | -$925K |
|
|
GB
104
DELISTED
Global Blue Group Holding
GB
| $7.44M | 0.11% |
+1,525,000
| New | +$7.44M |
|
105
TSMC
TSM
$1.2T
| $7.27M | 0.11% |
72,000
-20,000
| -22% | -$2.02M |
|
106
Sol-Gel Technologies
SLGL
$63.2M
| $6.6M | 0.1% |
220,800
-20,000
| -8% | -$598K |
|
107
M&T Bank
MTB
$31.3B
| $6.19M | 0.09% |
50,000
-50,000
| -50% | -$6.19M |
|
|
SGEN
108
DELISTED
Seagen Inc. Common Stock
SGEN
| $6.16M | 0.09% |
+32,000
| New | +$6.16M |
|
109
Marriott International Class A Common Stock
MAR
$72.7B
| $5.88M | 0.09% |
+32,000
| New | +$5.88M |
|
110
Western Alliance Bancorporation
WAL
$9.99B
| $5.84M | 0.08% |
+160,000
| New | +$5.84M |
|
111
Hilton Worldwide
HLT
$64.9B
| $5.82M | 0.08% |
+40,000
| New | +$5.82M |
|
112
X4 Pharmaceuticals
XFOR
$70.3M
| $5.77M | 0.08% |
+99,200
| New | +$5.77M |
|
113
Spectrum Brands
SPB
$1.33B
| $5.7M | 0.08% |
73,000
-282,000
| -79% | -$22M |
|
114
Nike
NKE
$111B
| $5.3M | 0.08% |
+48,000
| New | +$5.3M |
|
115
Advantage Solutions
ADV
$570M
| $4.94M | 0.07% |
2,111,000
| – | – |
|
116
Reviva Pharmaceuticals
RVPH
$31.2M
| $4.83M | 0.07% |
+824,000
| New | +$4.83M |
|
117
Victoria's Secret
VSCO
$1.87B
| $4.65M | 0.07% |
266,769
+102,154
| +62% | +$1.78M |
|
|
SURF
118
DELISTED
Surface Oncology, Inc. Common Stock
SURF
| $4.25M | 0.06% |
+4,890,000
| New | +$4.25M |
|
|
BFX
119
DELISTED
BowFlex Inc.
BFX
| $4.01M | 0.06% |
+3,290,638
| New | +$4.01M |
|
120
Las Vegas Sands
LVS
$37.8B
| $3.92M | 0.06% |
+67,500
| New | +$3.92M |
|
|
CMRX
121
DELISTED
Chimerix, Inc.
CMRX
| $3.84M | 0.06% |
3,176,000
-100,000
| -3% | -$121K |
|
122
Mohawk Industries
MHK
$8.18B
| $3.71M | 0.05% |
+36,000
| New | +$3.71M |
|
|
ELEV
123
DELISTED
Elevation Oncology
ELEV
| $3.64M | 0.05% |
+2,396,000
| New | +$3.64M |
|
124
Coeptis Therapeutics
COEP
$59.6M
| $3.61M | 0.05% |
+116,550
| New | +$3.61M |
|
|
CKPT
125
DELISTED
Checkpoint Therapeutics
CKPT
| $3.49M | 0.05% |
+1,413,000
| New | +$3.49M |
|